Ziprasidone Mesylate 51662-1564-03
- Manufacturer
- Hf Acquisition Co Llc, Dba Healthfirst
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intramuscular
- Product Type
- Human Prescription Drug
- Marketing Start
- July 17, 2021
- Listing Expires
- December 31, 2026
- Application
- ANDA211908
Need to source Ziprasidone Mesylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ziprasidone Mesylate | 20 mg/mL |
Drug Class
Atypical Antipsychotic [EPC]
Selected Package
51662-1564-03Selected10 POUCH in 1 CASE (51662-1564-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1564-2) / 5 mL in 1 VIAL, SINGLE-DOSE